We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyden Questions Pfizer on Lyrica Price Hikes
Sen. Ron Wyden (D-Ore.), the ranking member of the Senate Finance Committee, is seeking an explanation for the steadily growing cost of Pfizer’s blockbuster drug Lyrica.